Imunon, Inc.
IMNN
$1.59
$0.085.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 12.08% | -28.50% | -44.51% | 309.21% | 844.09% |
| Gross Profit | -12.08% | 28.50% | 44.51% | -309.21% | -844.09% |
| SG&A Expenses | -6.45% | -11.56% | -8.32% | -12.30% | -13.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.40% | -18.91% | -23.43% | -30.63% | -19.48% |
| Operating Income | 7.40% | 18.91% | 23.43% | 30.63% | 19.48% |
| Income Before Tax | 6.55% | 17.71% | 22.15% | 30.88% | 18.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.55% | 17.71% | 22.15% | 26.33% | 12.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.55% | 17.71% | 22.15% | 26.33% | 12.92% |
| EBIT | 7.40% | 18.91% | 23.43% | 30.63% | 19.48% |
| EBITDA | 7.81% | 19.48% | 24.00% | 30.94% | 19.58% |
| EPS Basic | 67.17% | 66.40% | 61.15% | 60.13% | 51.52% |
| Normalized Basic EPS | 67.20% | 66.40% | 61.15% | 62.88% | 54.73% |
| EPS Diluted | 67.17% | 66.40% | 61.15% | 60.13% | 51.52% |
| Normalized Diluted EPS | 67.20% | 66.40% | 61.15% | 62.88% | 54.73% |
| Average Basic Shares Outstanding | 211.91% | 163.81% | 109.36% | 97.72% | 79.49% |
| Average Diluted Shares Outstanding | 211.91% | 163.81% | 109.36% | 97.72% | 79.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |